234 related articles for article (PubMed ID: 33761608)
21. Long non-coding RNA FENDRR inhibits NSCLC cell growth and aggressiveness by sponging miR-761.
Zhang MY; Zhang ZL; Cui HX; Wang RK; Fu L
Eur Rev Med Pharmacol Sci; 2018 Dec; 22(23):8324-8332. PubMed ID: 30556873
[TBL] [Abstract][Full Text] [Related]
22. Long non-coding RNA FENDRR regulates IFNγ-induced M1 phenotype in macrophages.
Munteanu MC; Huang C; Liang Y; Sathiaseelan R; Zeng X; Liu L
Sci Rep; 2020 Aug; 10(1):13672. PubMed ID: 32792604
[TBL] [Abstract][Full Text] [Related]
23. Long noncoding RNA GAS8-AS1: A novel biomarker in human diseases.
Li G; Zhang T; Huang K; Zhu Y; Xu K; Gu J; Huang S; Gu C; Zhan R; Shen J
Biomed Pharmacother; 2021 Jul; 139():111572. PubMed ID: 33838502
[TBL] [Abstract][Full Text] [Related]
24. Small nucleolar RNA host gene 8: A rising star in the targets for cancer therapy.
Yuan X; Yan Y; Xue M
Biomed Pharmacother; 2021 Jul; 139():111622. PubMed ID: 33894626
[TBL] [Abstract][Full Text] [Related]
25. Long noncoding RNAs in cancer: From discovery to therapeutic targets.
Choudhari R; Sedano MJ; Harrison AL; Subramani R; Lin KY; Ramos EI; Lakshmanaswamy R; Gadad SS
Adv Clin Chem; 2020; 95():105-147. PubMed ID: 32122521
[TBL] [Abstract][Full Text] [Related]
26. Integrated Analysis of lncRNAs and mRNAs Identifies a Potential Driver lncRNA
Duan Y; Li WX; Wang Y; Zhao Y; Shen J; Deng CJ; Li Q; Chen R; Liu X; Zhang YL
Nutr Cancer; 2021; 73(6):983-995. PubMed ID: 32590916
[TBL] [Abstract][Full Text] [Related]
27. Long noncoding RNA TP73-AS1 in human cancers.
Chu F; Xue L; Miao H
Clin Chim Acta; 2020 Jan; 500():104-108. PubMed ID: 31678571
[TBL] [Abstract][Full Text] [Related]
28. The effect of splicing MST1R in gastric cancer was enhanced by lncRNA FENDRR.
Zhou D; Zhu X; Wu X; Zheng J; Tou L; Zhou Y
Exp Ther Med; 2021 Aug; 22(2):798. PubMed ID: 34093754
[TBL] [Abstract][Full Text] [Related]
29. LncRNA FENDRR suppresses the progression of NSCLC via regulating miR-761/TIMP2 axis.
Zhang G; Wang Q; Zhang X; Ding Z; Liu R
Biomed Pharmacother; 2019 Oct; 118():109309. PubMed ID: 31545237
[TBL] [Abstract][Full Text] [Related]
30. Promising role of long non-coding RNA PCAT6 in malignancies.
Li M; Yu X; Zheng Q; Zhang Q; He Y; Guo W
Biomed Pharmacother; 2021 May; 137():111402. PubMed ID: 33761616
[TBL] [Abstract][Full Text] [Related]
31. The long non-coding RNA Fendrr links epigenetic control mechanisms to gene regulatory networks in mammalian embryogenesis.
Grote P; Herrmann BG
RNA Biol; 2013 Oct; 10(10):1579-85. PubMed ID: 24036695
[TBL] [Abstract][Full Text] [Related]
32. Dysregulation of lncRNAs in circulation of patients with periodontitis: results of a pilot study.
Ghafouri-Fard S; Gholami L; Badrlou E; Sadeghpour S; Nazer N; Shadnoush M; Sayad A; Taheri M
BMC Oral Health; 2021 Sep; 21(1):471. PubMed ID: 34563175
[TBL] [Abstract][Full Text] [Related]
33. Circulating long non-coding RNAs in cancer: current status and future perspectives.
Qi P; Zhou XY; Du X
Mol Cancer; 2016 May; 15(1):39. PubMed ID: 27189224
[TBL] [Abstract][Full Text] [Related]
34. TUG1: a pivotal oncogenic long non-coding RNA of human cancers.
Li Z; Shen J; Chan MT; Wu WK
Cell Prolif; 2016 Aug; 49(4):471-5. PubMed ID: 27339553
[TBL] [Abstract][Full Text] [Related]
35. The long noncoding RNA landscape of neuroendocrine prostate cancer and its clinical implications.
Ramnarine VR; Alshalalfa M; Mo F; Nabavi N; Erho N; Takhar M; Shukin R; Brahmbhatt S; Gawronski A; Kobelev M; Nouri M; Lin D; Tsai H; Lotan TL; Karnes RJ; Rubin MA; Zoubeidi A; Gleave ME; Sahinalp C; Wyatt AW; Volik SV; Beltran H; Davicioni E; Wang Y; Collins CC
Gigascience; 2018 Jun; 7(6):. PubMed ID: 29757368
[TBL] [Abstract][Full Text] [Related]
36. Long non-coding RNA BLACAT1, a novel promising biomarker and regulator of human cancers.
Zhu M; Li X; Zhu S; Li P; Min L; Zhang S
Biomed Pharmacother; 2020 Dec; 132():110808. PubMed ID: 33113422
[TBL] [Abstract][Full Text] [Related]
37. PANDAR: a pivotal cancer-related long non-coding RNA in human cancers.
Li J; Li Z; Zheng W; Li X; Wang Z; Cui Y; Jiang X
Mol Biosyst; 2017 Oct; 13(11):2195-2201. PubMed ID: 28976505
[TBL] [Abstract][Full Text] [Related]
38. Identification of MFI2-AS1, a Novel Pivotal lncRNA for Prognosis of Stage III/IV Colorectal Cancer.
Luo R; Song J; Zhang W; Ran L
Dig Dis Sci; 2020 Dec; 65(12):3538-3550. PubMed ID: 31960204
[TBL] [Abstract][Full Text] [Related]
39. Potential of long non-coding RNAs in cancer patients: From biomarkers to therapeutic targets.
Chandra Gupta S; Nandan Tripathi Y
Int J Cancer; 2017 May; 140(9):1955-1967. PubMed ID: 27925173
[TBL] [Abstract][Full Text] [Related]
40. The role of a ceRNA regulatory network based on lncRNA MALAT1 site in cancer progression.
Su K; Wang N; Shao Q; Liu H; Zhao B; Ma S
Biomed Pharmacother; 2021 May; 137():111389. PubMed ID: 33601150
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
